Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Gains from Investment Securities (2021 - 2024)

Kezar Life Sciences (KZR) has disclosed Gains from Investment Securities for 4 consecutive years, with -$8000.0 as the latest value for Q4 2024.

  • For Q4 2024, Gains from Investment Securities changed N/A year-over-year to -$8000.0; the TTM value through Dec 2024 reached $270000.0, down 27.03%, while the annual FY2025 figure was -$290000.0, 3525.0% down from the prior year.
  • Gains from Investment Securities hit -$8000.0 in Q4 2024 for Kezar Life Sciences, down from $173821.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $15.3 million in Q2 2024 and bottomed at -$1.4 million in Q4 2021.
  • Average Gains from Investment Securities over 4 years is $1.4 million, with a median of $136910.5 recorded in 2022.
  • Year-over-year, Gains from Investment Securities plummeted 97.01% in 2022 and then skyrocketed 2212.03% in 2024.
  • Kezar Life Sciences' Gains from Investment Securities stood at -$1.4 million in 2021, then skyrocketed by 99.44% to -$8000.0 in 2022, then soared by 12425.28% to $986022.0 in 2023, then tumbled by 100.81% to -$8000.0 in 2024.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$8000.0, $173821.0, and $15.3 million for Q4 2024, Q3 2024, and Q2 2024 respectively.